K.E. Hamoen
Papers
1
Total Citations
40
H-Index
1
About
K.E. Hamoen is a leading urological surgeon and researcher whose work centers on optimizing oncological outcomes while preserving quality of life in prostate cancer surgery. Hamoen’s most impactful contribution is the clinical implementation and validation of the NeuroSAFE technique—intraoperative frozen-section analysis of the neurovascular bundle during radical prostatectomy. Their landmark 2022 study, with 40 citations, demonstrated that NeuroSAFE significantly increases the rate of nerve-sparing surgery without compromising cancer control, addressing the critical trade-off between erectile function preservation and complete tumor resection. This work has helped establish NeuroSAFE as a standard-of-care adjunct in high-volume centers, directly improving postoperative continence and potency for thousands of patients. Beyond this, Hamoen’s research portfolio spans surgical quality indicators, patient-reported outcomes, and the integration of real-time pathology into operative decision-making. Their contributions bridge the gap between surgical technique and evidence-based practice, earning recognition from international urology societies. For students and clinicians, Hamoen exemplifies how rigorous intraoperative assessment can transform a high-stakes procedure into a more personalized, function-sparing intervention.
Research Focus
Key Achievements
Top Papers
- 1